InsidersTradesSigma
Follow the AIS stock price and the full directors' dealings record of the company, a listed equity based in Australia. Shares are quoted on the AU market, under the authority of ASX. Operating in the Health Care sector, AIS has published 2 public disclosures. Market capitalisation: €586.9m. The latest transaction was disclosed on 6 July 2026 (Cease Substantial Holding). Among the most active insiders: 2. Changes in relevant interests. All data is openly available.
2
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate AIS Strong Buy (bullish), based on 6 analysts. Average price target: A$0.66.
13Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,647 of 28,835 companies
31.8
score / 100
Value22
Quality41
FCF yld-5.1%
Earn yld-4.0%
EV/EBITDA20.7x
ROE17%
Gross mgn13%
Net mgn-4.5%
Debt/EBITDA1.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 6 July 2026
Declarations2 total
ShareASXASX:2924-03108267-6A1332667
ShareASXASX:2924-03089818-6A1325376
2 of 2 declarations
About AIS
AIS is a company operating in the healthcare and pharmaceutical sector, listed on the XASX.
